Home/XYRA/Dr Samuel G Latham

DS

Dr Samuel G Latham

Member

Therapeutic Areas

XYRA Pipeline

Drug	Indication	Phase
Budiodarone	Atrial Fibrillation	Phase 2

Leadership Team at XYRA

Dr Peter G Milner

Managing Member

Dr Pascal J Druzgala

Managing Member

Dr Margaret Ziola

Dr Christian D Flynn

Dr Stephen McKeever

View full XYRA profile